Glucose production
1 paper1 finding
- Human trial1
Interventions
1Metformin
downin humans1
1 study
Metformin
downin humans1
Metformin decreases glucose production in humans (-24% (P = 0.0009)).
“Metformin reduced that rate by 24% (to 0.53 +/- 0.03 mmol x m(-2) x min(-1), P = 0.0009)”
Human trialin type 2 diabetic subjects3 monthsn = 7
Mechanism by which metformin reduces glucose production in type 2 diabetes
Diabetes1 Dec 2000
Latest
4 in 12 monthsBiochemistry and Biophysics Reports
Distinct metabolomic signatures of SGLT2 inhibitor vs. sulfonylurea in a paired human liver biopsy study
Randomised trial in peopleInterventions
The Journal of Clinical Endocrinology and Metabolism
Quantitative Insights into Tirzepatide and Semaglutide Using Longitudinal Systems Modeling
Computational studyTirzepatide
Handbook of Experimental Pharmacology
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals
ReviewSGLT2 inhibitors
ADA Scientific Sessions 2026 Abstract
Forty Weeks of Metformin Alters Regional Insulin Sensitivity but Not Mitochondrial Function in Insulin-Resistant Adults
Randomised trial in 40 peopleMetformin
ADA Scientific Sessions 2025 Abstract
Forty-Weeks of Metformin Improves Glucose Tolerance without Alterations in Skeletal Muscle Mitochondrial Function and Aerobic Capacity
Randomised trial in 40 peopleMetformin
Clinical and Translational Medicine
Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial
Non-randomised trial in 8 peopleEndothelial dysfunction
Biomedicines
Supplementing Glycine and N-acetylcysteine (GlyNAC) in Aging HIV Patients Improves Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Endothelial Dysfunction, Insulin Resistance, Genotoxicity, Strength, and Cognition: Results of an Open-Label Clinical Trial
Non-randomised trial in peopleEndothelial dysfunction
Nature Metabolism
Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss
Experiments in miceMetformin
Diabetes
Mechanism by which metformin reduces glucose production in type 2 diabetes
Non-randomised trial in peopleMetformin